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Items for this week’s EPI Update include: 
• Zika travel recommendations lifted for Miami-Dade County 
• CDC Vital Signs: Legionella 
• FDA requests removal of Opana ER for risks related to abuse 
• Infographic: Don’t let a tick make you sick! 
• Meeting announcements and training opportunities 
 
Zika travel recommendations lifted for Miami-Dade County 
As of June 2, the Zika cautionary (yellow) area designation in Miami-Dade County in Florida has been lifted 
because more than three mosquito incubation periods (45 days) passed with no local transmission cases 
identified via enhanced surveillance. Lifting the yellow area designation means there are no longer any travel 
recommendations related to Zika virus for Miami-Dade County. 
 
Because of the severe effects of Zika virus infection during pregnancy, it is recommended that people living in 
or traveling to Miami-Dade County continue to protect themselves from mosquito-borne illnesses, including 
Zika virus.  
 
For more information, visit https://www.cdc.gov/zika/geo/post-cautionary-guidance.html.  
 
CDC Vital Signs: Legionella 
CDC reviewed legionella surveillance data from 21 jurisdictions around the U.S., finding 3 percent of the 2,809 
cases were definitely and 17 percent were possibly health care associated. Most (88 percent) of the health care 
associated cases occurred in those 60 years of age and older. The case fatality rate among health care 
associated cases was as high as 25 percent.   
 
To view the full article, visit https://www.cdc.gov/mmwr/volumes/66/wr/mm6622e1.htm.  
 
FDA requests removal of Opana ER for risks related to abuse 
The FDA has requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER 
(oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal 
based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the 
agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public 
health consequences of abuse. 
 
To view the full press release, 
visit https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm562401.htm.  
 
Infographic: Don’t let a tick make you sick! 
 
  
To view in full size, visit https://www.cdc.gov/lyme/resources/toolkit/dontletticksbitemecomicfs_508.pdf 
 
Meeting announcements and training opportunities 
July 19-20, SHL is hosting the two-day Iowa Clinical Laboratory Biosafety Practices and Procedures Workshop 
for clinical laboratory staff, infection control professionals, biosafety professionals, and current laboratory 
science students. Registration is limited to the first 40 people. Costs for hotel (night of July 19th ONLY), per 
diem for food, and mileage will be covered by SHL. The deadline for hotel reservation requests is June 23, but 
if you don’t need a hotel room the registration deadline is July 12. 
 
To learn more about the workshop and to register, visit www.eventbrite.com/e/iowa-clinical-laboratory-
biosafety-practices-procedures-workshop-registration-34989005056?aff=es2. 
 
Have a healthy and happy week! 
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